about
Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.Sub-optimal Testing and Awareness of HCV and HBV Among High Risk Individuals at an Underserved Safety-Net Hospital.Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.Pilot Study of Screening Patients for Hepatitis C Virus Infection During Outpatient Endoscopy.A Pilot Program Integrating Hepatitis B Virus (HBV) Screening into an Outpatient Endoscopy Unit Improves HBV Screening Among an Ethnically Diverse Safety-Net Hospital.Significantly Higher Mortality Following Liver Transplantation Among Patients Aged 70 Years and Older.Optimal timing for hepatitis C antiviral therapy in the peritransplant period?Improved Liver Transplant Waitlist Mortality and Lower Risk of Disease Progression Among Chronic Hepatitis C Patients Awaiting Liver Transplantation After the Introduction of Direct Acting Antiviral Therapies in the United StatesAdvanced Hepatocellular Carcinoma Tumor Stage at Diagnosis in the 1945-1965 Birth Cohort Reflects Poor Use of Hepatocellular Carcinoma ScreeningGlobal HBV burden: guesstimates and factsHas Access to HCV Therapy Changed for Patients with Mental Health or Substance Use Disorders in the DAA Period?More severe deficits in functional status associated with higher mortality among adults awaiting liver transplantationNonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older AgeAssessing the safety of beta-blocker therapy in cirrhosis patients with ascites: A meta-analysisUpdated Assessment of Colorectal Cancer Incidence in the U.S. by Age, Sex, and Race/EthnicityLetter: significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the USA: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey - author's replyIncreasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient SampleDecreasing frequency and improved outcomes of hepatitis C-related liver transplantation in the era of direct-acting antivirals - a retrospective cohort studyIncreasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitisCorrection to: Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older AgePatients With Acute on Chronic Liver Failure Grade 3 Have Greater 14-Day Waitlist Mortality Than Status-1a PatientsNonsurgical options for localized hepatocellular carcinomaRace/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient SampleEvaluation and management of acute and chronic portal vein thrombosis in patients with cirrhosisNonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare dataReply
P50
Q38601056-3A80902C-33D5-46AF-9A60-D8CBFB998250Q38974928-9B33DAFA-16D8-4152-A952-52BDD4DF4FF2Q40039094-1F4A771B-1F5E-4553-9F80-EEB0C9A71510Q40146605-D7327BA1-FF4F-4E3F-AC69-D56BB267E47AQ40172735-09CE762D-4CF3-4622-BF16-794E3EFD4B57Q40214331-09231018-F685-4D59-B676-214AE84185FAQ40302269-F32D746E-AFA4-406A-BBA7-41294DAF1102Q41921928-43F72C9F-4484-4F44-9B62-1C6A1D0F0547Q45323738-85510550-A2E0-4736-921F-A7CF2F628A06Q47396134-CE3B4340-9A78-4C98-BD12-FB57DA3A27E4Q47753414-A7178A52-081E-420B-B153-FD1B1A3C38CFQ58567315-0B5FFCC4-6015-47A5-89E2-F44B69A325BBQ58697778-23FE6E79-D945-4355-BF74-89A6AFF3B4BFQ59355831-3E714DB0-1039-4376-9B2A-D68F2324470EQ59356597-3C6EE6A4-42B4-4F73-A7AA-265400FBCA3AQ89444481-FBB6771F-0820-4ECB-8D67-A354ED2547A0Q89558079-C8908097-AD53-44E5-BFE3-D5AB6BA9CDF7Q90894636-B0306C6E-8F58-4508-9CA3-DD1142B13932Q90917262-3190804D-283B-4835-8DED-7A6BE93C6AD4Q91179831-F5B8C64A-D55E-4AB9-AB29-D21AFBB861A6Q91195666-0AA0C5C8-17AB-4CD8-8F68-3D3F394856F8Q92317894-DC75BA09-07B9-4555-8DA1-F5E7A6BD725FQ92331960-35A82942-6A75-4E29-9D5A-372DEBB11D81Q92340368-D77F960E-8D6F-471E-865B-E00D3945C68AQ92409380-301BBF30-2C9E-496C-8ED5-F8A4EEF12FBAQ92599697-816963C1-2040-4CD9-A45A-CDF03228089AQ92670144-F62CC828-24C4-4A1C-9255-99333336577FQ93138677-98CCFF5C-D1CA-4944-A367-22DE5F265BF4Q93140272-D407114B-B379-46B6-9E6A-0F1E27D4F57DQ94558360-77D43E4D-532F-4B55-B463-687B145DB3DCQ95569190-3CE96046-FF52-4941-AEEF-98A1F3C441D5
P50
description
researcher
@en
wetenschapper
@nl
name
Robert J Wong
@en
Robert J Wong
@nl
type
label
Robert J Wong
@en
Robert J Wong
@nl
prefLabel
Robert J Wong
@en
Robert J Wong
@nl
P31
P496
0000-0002-8923-2806